Pulmonary Vasodilating Effects of a New Drug Formulation Containing a NO Donor Metabolite (SIN-1A) stabilized by CD
Sin1A is an unstable NO releasing metabolite of Molsidomine. Molsidomine is a prodrug that undergoes first-pass metabolism in the liver,